TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,513 | +6.8% | 421 | +8.5% | 0.00% | 0.0% |
| Q2 2023 | $6,096 | -4.7% | 388 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6,395 | +44.8% | 388 | +37.1% | 0.00% | 0.0% |
| Q4 2022 | $4,415 | +120.8% | 283 | +91.2% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | 0.0% | 148 | +32.1% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | 0.0% | 112 | -36.4% | 0.00% | 0.0% |
| Q4 2021 | $2,000 | -50.0% | 176 | -32.8% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | – | 262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |